NCT00003101 - Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

lomustine

DRUG

procarbazine hydrochloride

DRUG

thiotepa

DRUG

vincristine sulfate

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (7)

10021

Memorial Sloan-Kettering Cancer Center, New York

35294

University of Alabama Comprehensive Cancer Center, Birmingham

60153

Loyola University Medical Center, Maywood

60201

Evanston Northwestern Health Care, Evanston

94305-5408

Stanford University Medical Center, Stanford

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER